Digital Therapeutics Market to Gain Prominence by 2027 - PowerPoint PPT Presentation

About This Presentation
Title:

Digital Therapeutics Market to Gain Prominence by 2027

Description:

According to a new market research study titled ‘Digital Therapeutics Market to 2025 – Global Analysis and Forecasts by Application and Distribution Channel, the global digital therapeutics market was valued at US$ 1,993.2 Mn in 2017 and is estimated to reach US$ 8,941.1 Mn by 2025. The market is estimated to grow with a CAGR of 20.8% from 2018-2025. The report highlights the trends prevalent in the global digital therapeutics market and the factors driving the market along with those that act as deterrents to its growth. Download Sample Copy at – PowerPoint PPT presentation

Number of Views:42

less

Transcript and Presenter's Notes

Title: Digital Therapeutics Market to Gain Prominence by 2027


1
Digital Therapeutics Market
Publication Month  Aug 2018 No. of Pages 150
 Report Code TIPHE100000856    Category
Medical Device
Digital Therapeutics Market to 2025- Global
Analysis and Forecasts by Application (Diabetes,
Cardiovascular Diseases, Central Nervous System
(CNS) Disease, Respiratory Diseases, Smoking
Cessation, Musculoskeletal Diseases, Others)
Distribution Channel (Patients, Providers,
Payers, and Employers) and Geography
E-Mail  sales_at_theinsightpartners.com
2
Digital Therapeutics Market
Publication Month  Aug 2018 No. of Pages 150
 Report Code TIPHE100000856    Category
Medical Device
Introduction According to a new market research
study titled Digital Therapeutics Market to 2025
Global Analysis and Forecasts by Application
and Distribution Channel, the global digital
therapeutics market was valued at US 1,993.2 Mn
in 2017 and is estimated to reach US 8,941.1 Mn
by 2025. The market is estimated to grow with a
CAGR of 20.8 from 2018-2025.The report
highlights the trends prevalent in the global
digital therapeutics market and the factors
driving the market along with those that act as
deterrents to its growth. Global digital
therapeutics market, based on the application is
segmented into diabetes, cardiovascular disease,
central nervous system disease, respiratory
diseases, smoking cessation, musculoskeletal
disease and others. In 2017, diabetes segment
held the largest share, by application. The
segment is also anticipated to grow at a
significant rate during the forecast period,
since there has been an increase in the incidence
of diabetes across the globe.
E-Mail  sales_at_theinsightpartners.com
3
Digital Therapeutics Market
Publication Month  Aug 2018 No. of Pages 150
 Report Code TIPHE100000856    Category
Medical Device
Global digital therapeutics market is expected to
grow in the coming years, owing to the rising
pressure on healthcare providers to reduce
healthcare cost in the market. The fiscal
pressure and patent cliffs compel healthcare
providers to cut on drug prices, encourage the
use of generics and scale back the reimbursement.
This in turn is gradually reducing the profit
margins and annual net sales of the healthcare
companies that leads to immediate requirement of
a strategic plan so as to cut down on the
operational costs. The report provides a
detailed overview on the industry including both
qualitative and quantitative information. It
provides overview and forecast of the global
Digital Therapeutics market based on products,
application, and end users. It also provides
market size and forecast till 2025 for overall
Digital Therapeutics market with respect to five
major regions, namely North America, Europe,
Asia-Pacific (APAC), Middle East and Africa (MEA)
and South Central America. The market by each
region is later sub-segmented by respective
countries and segments. The report covers
analysis and forecast of 13 countries globally
along with current trend and opportunities
prevailing in the region. The report analyzes
factors affecting market from both demand and
supply side and further evaluates market dynamics
effecting the market during the forecast period
i.e., drivers, restraints, opportunities, and
future trend. The report also provides exhaustive
PEST analysis for all five regions namely North
America, Europe, APAC, MEA and South Central
America after evaluating political, economic,
social and technological factors effecting the
market in these regions.
E-Mail  sales_at_theinsightpartners.com
4
Digital Therapeutics Market
Publication Month  Aug 2018 No. of Pages 150
 Report Code TIPHE100000856    Category
Medical Device
Strategic Insights Product launch/update and
partnerships were observed as the most adopted
strategy in global digital therapeutics industry.
Few of the product approvals and partnerships
made by the players in the market are listed
below 2017 In November, Propeller Health and
Express Scripts entered into a partnership to
provide Propellers FDA-cleared digital solutions
to Express Scripts to manage asthma or COPD.
2016 In November, Propeller Health received
FDA approval for its Propeller platform for use
with GSKs Ellipta inhaler. 2018 In April,
Canary Health entered into a partnership with
NMRHCA to offer the Better Choices, Better Health
(BCBH) digital therapeutics program in New
Mexico. 2016 In June, Canary Health partnered
with Medtronic to expand their diabetes care
offerings with Canary Health's self-management
suite for pre-diabetes, diabetes and related
comorbidities. Get a PDF Sample copy of Digital
Therapeutics Market https//www.theinsightpartner
s.com/sample/TIPHC00002236
E-Mail  sales_at_theinsightpartners.com
5
Digital Therapeutics Market
Publication Month  Aug 2018 No. of Pages 150
 Report Code TIPHE100000856    Category
Medical Device
  • The List of Companies
  • Propeller Health
  • CANARY HEALTH
  • Noom, Inc.
  • 2Morrow Inc.
  • Livongo Health
  • Proteus Digital Health
  • WellDoc, Inc.
  • Fitbit, Inc.
  • Omada Health, Inc.
  • MANGO HEALTH
  • Inquire more _at_ https//www.theinsightpartners.com/
    inquiry/TIPHC00002236

E-Mail  sales_at_theinsightpartners.com
Write a Comment
User Comments (0)
About PowerShow.com